Live guidance on setting SBTi-aligned targets for pharmaceutical businesses
This webinar will give you direct guidance on how GHG baselines, SBTi targets and feasibility assessments can be set and completed in a matter of months with the right support, including an overview of the new expectations and how suppliers can respond to them quickly.
In 2026, SBTi-aligned targets are becoming a minimum entry requirement for tier 1 pharma suppliers, both in new tenders and to retain existing business relationships. Large pharma companies are moving to reduce their Green House Gas (GHG) emissions, the majority of which are found in Scope 3 emissions.
As such, these expectations are being pushed down to tier 1 suppliers and if businesses can’t demonstrate readiness or a commitment to reduce aligned with the SBTi, they risk being excluded from the procurement process entirely.
What the webinar will cover:
- What’s driving SBTi target pressure in the pharma supply chain
- What tier 1 suppliers must do to remain competitive
- How to baseline Scope 1–3 emissions credibly
- How to create and submit SBTi aligned targets aligned to the best practices
Our panelists
Alexander Morden
Senior Manager & Head of Life Science
Position Green
Antonella Cistari
Advisor
Position Green
Bertie Nuttall
Content Marketing Manager
Position Green
Christoffer Falkman
ESG Director
Bavarian Nordic
